Announcement of the BOD resolved to release of
non-compete restrictions for the manager
Date of events
2022/08/12
To which item it meets
paragraph 21
Statement
1.Date of the board of directors resolution:2022/08/12
2.Name and title of the managerial officer with
permission to engage in competitive conduct:
Wan-Jiun Chen /Vice president of the R&D Center
3.Items of competitive conduct in which the officer is
permitted to engage:
Representative juristic-person director of Diamond Biofund Inc.
4.Period of permission to engage in the competitive
conduct:
Within period serving as the manager in the Company.
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 32 of the
Company Act):
Approved without objection by the directors present.
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
title of the managerial officer (if it is not the
operator of a mainland China enterprise, please enter
"N/A" below):N/A
7.Company name of the mainland China enterprise and the
officer's position in the enterprise:N/A
8.Address of the mainland China enterprise:N/A
9.Operations of the mainland China enterprise:N/A
10.Impact on the company's finance and business:
Diamond Biofund Inc. is invested by the company and its profits or
losses is recognized by equity method.
11.If the managerial officer or director has invested in
the mainland China enterprise, the monetary amount of the
investment and the officer or director's shareholding ratio:N/A
12.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
Microbio Co. Ltd. published this content on 12 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 August 2022 09:19:04 UTC.
Microbio Co., Ltd. is a Taiwan-based company primarily engaged in the research, development, manufacture, distribution and wholesales of healthcare food products and pharmaceuticals. The Company provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The Company mainly distributes its products mainly within domestic market.